National Institutes of Health

Title (Tablepress)OrganizationLOI DateStart Time (Calender)Keywords
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)National Institutes of Health2/13/2024Clinical Trials, Early-stage, diagnosis, precention, disparities, molecules, xenograft, biology
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)National Institutes of Health1/14/20242/14/2024Gut, Diet, lipids, biology, early-stage, biochemistry
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)National Institutes of Health2/14/2024early-stage, postdoctoral, cancer control, cancer prevention, data science
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)National Institutes of Health2/14/2024early-stage, postdoctoral, cancer control, cancer prevention, data science
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)National Institutes of Health1/14/20242/14/2024Gut, Diet, lipids, biochemistry, biology,
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)National Institutes of Health2/14/2024early-stage, postdoctoral, cancer control, cancer prevention, data science
Biology of Bladder Cancer (R21 Clinical Trial Optional)National Institutes of Health1/16/20242/16/2024Exploratory, biology, genetics, novel interventions,
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)National Institutes of Health1/16/20242/16/2024Investigator-Initiated Research, surgery, early-stage
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)National Institutes of Health2/16/2024Microbiome, imaging, therapy, immune response, preclinical, bacteria, exploratory
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)National Institutes of Health2/16/2024microbiome, immune response, novel molecules, early-stage
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)National Institutes of Health2/16/2024Cancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research,
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)National Institutes of Health2/16/2024Cancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research,
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)</National Institutes of Health2/16/2024Cancer Immunotherapy, B Cell Malignancies, Immunotherapeutic Interventions, Cancer Research
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)National Institutes of Health2/16/2024Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)National Institutes of Health1/16/20242/16/2024Mechanisms, Incretin mimetics, Clinical trial not allowed
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)National Institutes of Health2/20/2024molecular, biomarkers, therapies, clinical
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)National Institutes of Health2/20/2024molecular, biomarkers, therapies, clinical
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)National Institutes of Health1/20/20242/20/2024complementary and integrative health, clinical trials, mHealth, remote delivery, chronic diseases
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)National Institutes of Health2/20/2024 mind-body interventions, clinical trials, feasibility studies,
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)National Institutes of Health2/20/2024mind-body interventions, clinical trials, feasibility studies, multi-site research, chronic pain, stress management
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)National Institutes of Health1/26/20242/26/2024Biomedical Research, Biomedical Informatics, Scholarly Works, Health Informatics
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)National Institutes of Health2/28/2024Established, epidemiology, cancer control
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)National Institutes of Health2/28/2024epidemiology, diversity, risks, rural, poverty, population-based research, cohort
Postbaccalaureate Research Education Program (PREP)(R25 - Independent Clinical Trial Not Allowed)National Institutes of Health3/1/2024Postbaccalaureate training, research education, workforce development, non-clinical
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)National Institutes of Health3/8/2024High-end instruments, shared instrumentation, infrastructure, non-clinical
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)National Institutes of Health3/8/2024Shared instrumentation, infrastructure, equipment, non-clinical
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)National Institutes of Health3/12/2024Diversity, Research Scientist Development, Clinical Trial
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)National Institutes of Health2/13/20243/13/2024pediatrics, cancer genetics, birth defects, genetic research, rare diseases
Advanced Research Projects Agency for Health (ARPA-H) National Institutes of Health3/14/2024Biomedical Research, Health Technology, Disease Prevention, Biotechnology, Limited
Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants of Health to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Optional)National Institutes of Health3/22/2024Limited, social determinants of health, health equity, clinical-community partnerships, intervention research, vulnerable populations
Clinical-Community Linkages to Address Unmet Social Needs and Adverse Social Determinants of Health to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Optional)National Institutes of Health2/21/20243/22/2024Health equity, social determinants of health, community-based interventions, health disparities, underserved populations, clinical trials (optional)
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)National Institutes of Health2/22/20243/22/2024health disparities, social determinants, intervention research, SDOH
NCMRR Early Career Research Award (R03 Clinical Trial Optional)National Institutes of Health3/28/2024Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer Research
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)National Institutes of Health4/1/2024Early-stage, innovation,
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)National Institutes of Health3/1/20244/2/2024NHGRI technology development, coordinating center, clinical trials not allowed
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)National Institutes of Health4/7/2024Cancer Control, Population Sciences, Clinical Trial
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)National Institutes of Health4/8/2024Early-stage, predoctoral, training, clinical, fellowship, physician
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)National Institutes of Health4/8/2024Early-stage, predoctoral, training, clinical, fellowship, physician, Diversity,
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)National Institutes of Health4/8/2024Early-stage, predoctoral, training, clinical, fellowship, physician
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)National Institutes of Health4/8/2024Diet, gut microbiome, obesity, weight, policy,
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)National Institutes of Health4/8/2024Fellowship, Postdoctoral, early-stage, mentor,
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)National Institutes of Health4/30/2024Population assessment, Tobacco and health, Biospecimen access
Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)National Institutes of Health5/1/2024Mutant mice, resource centers, research, clinical trials not allowed
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)National Institutes of Health5/3/2024Nanotechnology, Brain Disorders, Biomedical Systems, Biomarkers
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)National Institutes of Health5/3/2024Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community Exposures
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)National Institutes of Health5/17/2024Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer Research
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)National Institutes of Health12/25/20235/25/2024investigator-initiated trial, prevention, dectetion, organ system, translational, genetic, biochemical,
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)National Institutes of Health5/25/2024Training, clinical, biomedical, innovation,
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)National Institutes of Health5/25/2024Health Careers Opportunity Program, Cancer Symptom Management, Gene Editing, Cancer Survivorship
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)National Institutes of Health5/25/2024Training, clinical, biomedical, innovation,
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)National Institutes of Health5/25/2024Training, clinical, biomedical, innovation,
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)National Institutes of Health5/29/2024early-stage investigators, basic research, human studies, innovative approaches, high-risk research
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)National Institutes of Health5/29/2024early-stage investigators, basic research, clinical trials (not allowed), innovative approaches, high-risk research
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)National Institutes of Health5/29/2024Early-stage investigators, clinical trials not allowed
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)National Institutes of Health5/29/2024Early-stage investigators, basic experimental studies, human subjects required
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional)National Institutes of Health4/30/20245/30/2024Regional genomic medicine, eConsult services, clinical trials (optional)
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial OptionalNational Institutes of Health2/25/20245/31/2024ultra-rare cancers, therapeutic development, FDA
Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)National Institutes of Health4/30/20245/31/2024radiation biodosimetry, assays, triage, predicting health outcomes, acute injuries, delayed injuries, public health emergency
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)National Institutes of Health6/5/2024Innovation, population research, occupation, work-place, disparities, diversity, social
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)National Institutes of Health1/5/20246/5/2024regenerative medicine, biomimetic, tissue engineering, biology, novel models, innovation
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)National Institutes of Health1/5/20246/5/2024collaborative, therapies, basic, translational, clinical, biomarkers,
Biology of Bladder Cancer (R01 Clinical Trial Optional)National Institutes of Health1/5/20246/5/2024biology, genetics, novel interventions,
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024Microbiome, imaging, therapy, immune response, preclinical, bacteria,
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)National Institutes of Health6/5/2024Innovation, patient-clinician, communication, disparities, diversity, outcomes, equity
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)National Institutes of Health1/5/20246/5/2024neuroscience, chemical probes, in vivo studies, drug discovery, neurotransmitters, brain imaging
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed?National Institutes of Health5/5/20246/5/2024global health, career development, collaborative research
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)National Institutes of Health1/5/20246/5/2024cancer prevention, clinical trials, intervention, lifestyle factors, environmental exposures
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)National Institutes of Health1/5/20246/5/2024clinical trials, early phase, treatment, diagnosis, innovative therapies
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)National Institutes of Health6/5/2024Health disparities, sexual and gender minorities (SGM), mental health, substance use, access to care, social determinants of health
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)National Institutes of Health12/29/20236/5/2024education, skills development, biomedical, development, predoctoral, postdoctoral
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)National Institutes of Health1/5/20246/5/2024Survivor, treatment, diversity, observational
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)National Institutes of Health1/5/20246/5/2024cancer imaging, inflammation, molecular imaging, PET, MRI, biomarkers, diagnosis, prognosis
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)National Institutes of Health6/5/2024Health disparities, Diversity, Equity, Inclusion,
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024microbiome, immune response, novel molecules,
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)National Institutes of Health6/5/2024Nanotechnology, Brain Disorders, Biomedical Systems, Biomarkers
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)National Institutes of Health6/5/2024SBIRT/P, Health Disparities, Clinical Trial, Adult Populations
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)National Institutes of Health1/5/20246/5/2024Investigator-Initiated Research, surgery,
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)National Institutes of Health1/5/20246/5/2024Mechanisms, Cancer risk, Incretin mimetics, Clinical trial optional
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024Animal models, Translational research,
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024Cancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research,
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)National Institutes of Health6/5/2024Cancer Health Disparities, Cutting-Edge Technologies, Digital Pathomics, Investigator-Initiated Research
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024Nanotechnology, Brain Disorders, Biomedical Systems, Biomarkers
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of Health6/5/2024Translational Research, Mammalian Models, Clinical Trial Not Allowed
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)National Institutes of Health12/11/20236/7/2024Clinical, biology, biomarker, clinical
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)National Institutes of Health5/7/20246/7/2024Exploratory, Early-stage, cancer control, novel
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)National Institutes of Health5/16/20246/16/2024immunity, immunological memory, immune system
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)National Institutes of Health5/16/20246/16/2024rained immunity, immune mechanisms, translational research, non-clinical
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)National Institutes of Health5/20/20246/20/2024Systems-level, mechanisms of responses. Therapy, novel, data,
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)National Institutes of Health5/20/20246/20/2024Complementary and integrative health, remote interventions, mHealth, clinical trials (required)
Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed)National Institutes of Health1/3/20247/1/2024Diversity, equity, and inclusion (DEIA), faculty hiring and advancement, institutional climate, surveys, action plans
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)National Institutes of Health6/1/20247/1/2024transdisciplinary, physician, chemistry, biology, innovation, theory,
Advancing Genomic Medicine Research (R21 Clinical Trial Optional)National Institutes of Health7/8/2024innovation, health disparities, genomic information, early-stage,
Advancing Genomic Medicine Research (R01 Clinical Trial Optional)National Institutes of Health7/8/2024innovation, health disparities, genomic information, early-stage,
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )National Institutes of Health5/12/20247/12/2024Early-Stage, Tobacco, postdoctoral,
Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)National Institutes of Health7/5/20248/5/2024prevention, health disparities, network, innovation,
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)National Institutes of Health12/29/20238/19/2024Diversity in health research, biomedical and behavioral sciences, underrepresented groups, research training
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)National Institutes of Health12/29/20239/30/2024Diversity, training, bioengineering, imaging, innovation, education,
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)National Institutes of Health10/11/2024education, skills development, biomedical, development, predoctoral, postdoctoral
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/1/2024Nanotechnology, Brain Disorders, Biomedical Systems, Biomarkers
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/1/2024Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health Disparities
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/1/2024Research Specialist, Laboratory-based Scientist
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of Health10/2/202311/1/2024Research Specialist, Core-based Scientist
Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)National Institutes of Health11/5/20231/29/2025education, skills development, biomedical, development, predoctoral, postdoctoral
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)National Institutes of Health1/30/2025diabetes, kidney diseases, digestive and blood diseases, education programs, training, curriculum development

Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.

NCI Cancer Center badge